Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4906 AL 4920

The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives

Baldasso GM, Paes RS, Moreira AG, Salvadori SG, Limberger C, Roviezzo F, Capasso R, Dutra RC.

Pharmacol Res. 2026 May;227:108185. doi: 10.1016/j.phrs.2026.108185. Epub 2026 Apr 3.

Exosome-mediated gut-brain axis signaling in neurodegenerative diseases: Mechanisms, experimental evidence, and therapeutic perspectives-A narrative review

Aggad WS, Ghosh R, Almohaimeed HM, Mohammedsaleh ZM, Saleh FM, Almars AI, Jyothi SR, Panigrahi R, Kumer A, Dhara B.

Animal Model Exp Med. 2026 May 26. doi: 10.1002/ame2.70226. Online ahead of print.

Huntington's disease is the best investment in neuroscience today

Maimon R.

Trends Mol Med. 2026 Mar;32(3):204-207. doi: 10.1016/j.molmed.2026.01.001. Epub 2026 Feb 14.

Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system

Siew JJ, Chern Y.

Neurobiol Dis. 2026 Jun 15;224:107410. doi: 10.1016/j.nbd.2026.107410. Epub 2026 Apr 24.

Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases

Bougea A.

Int J Mol Sci. 2026 Apr 3;27(7):3260. doi: 10.3390/ijms27073260.

Experiences and perceptions of affected individuals, families, caregivers and healthcare professionals regarding end-of-life planning in Huntington's disease: A narrative synthesis

Lyon C, Williams C, Buswell S, Lock S, Gunn S.

J Huntingtons Dis. 2026 Mar 16:18796397261428341. doi: 10.1177/18796397261428341. Online ahead of print.

Contribution of neuroepigenetics to HD - developmental and aging-related signatures

Scuto J, Penaud N, Merienne K.

J Huntingtons Dis. 2026 May;15(2):263-274. doi: 10.1177/18796397261426625. Epub 2026 Feb 27.

Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain

Bernatoniene J, Kopustinskiene DM, Casale R, Medoro A, Davinelli S, Saso L, Petrikonis K.

Pharmaceutics. 2026 Jan 16;18(1):118. doi: 10.3390/pharmaceutics18010118.

Ketamine as a potential cognitive enhancer in neurological disorders: evidence from preclinical and clinical studies

Leon-Rojas JE, Mascialino G, Vinueza Mera L, Hinojosa-Figueroa MS, Navas Arias CF, Cadena Barberis ED, Sacks-Zimmerman A.

Front Neurol. 2026 Mar 30;17:1786249. doi: 10.3389/fneur.2026.1786249. eCollection 2026.

Sexual dysfunction in movement disorders: prevalence, clinical features, associated factors and management

Leclercq V.

Clin Park Relat Disord. 2026 May 9;14:100452. doi: 10.1016/j.prdoa.2026.100452. eCollection 2026.

Tetrabenazine-Responsive Choreo-Ballism and Akathisia After Cardioversion and Coronary Angiography: A Case Report

Fatheel M, Karkout R.

Cureus. 2026 Apr 6;18(4):e106503. doi: 10.7759/cureus.106503. eCollection 2026 Apr.

The girl at the end of the world - a reflection on humanitarian and care work in Barranquitas, Venezuela

Fisher A.

J Huntingtons Dis. 2026 Jan 16:18796397261416568. doi: 10.1177/18796397261416568. Online ahead of print.

The Use of Cannabis-Based Medicine in Selected Neurological Disorders

Szejko N, Saramak K, Müller-Vahl KR.

Curr Top Behav Neurosci. 2026;76:433-454. doi: 10.1007/7854_2024_564.

Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation

Panchal D, Solanki D, Solanki R, Yadav AK, Bhatia D, Yadav P.

ACS Chem Neurosci. 2026 May 20;17(10):1824-1869. doi: 10.1021/acschemneuro.6c00245. Epub 2026 May 8.

Psychosis in Huntington disease: a short update

Jellinger KA.

J Neural Transm (Vienna). 2026 Apr 2. doi: 10.1007/s00702-026-03152-w. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias